Literature DB >> 19769487

Surgical management of cervical degenerative disease: the evidence related to indications, impact, and outcome.

Michael G Fehlings, Babak Arvin.   

Abstract

In this special edition of Journal of Neurosurgery: Spine, a series of systematic reviews sponsored by the Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons/Congress of Neurological Surgeons is presented. This collection of comprehensive reviews summarizes the medical evidence related to the surgical management of cervical degenerative disc disease. Several of the key conclusions are discussed in this introduction to the issue: There is Class II evidence to suggest that the clinical condition remains stable when observed over a 3-year period in patients with mild-to-moderate cervical spondylotic myelopathy (CSM) and age younger than 75 years. There is consistent Class III evidence that the duration of symptoms, and possibly advancing age, negatively affect outcome in patients with CSM. There is Class II evidence that somatosensory evoked potentials have prognostic value in patients with CSM. There is Class I evidence to show that electromyographic abnormalities (as well as the presence of radiculopathy) are predictive of the development of myelopathy in minimally symptomatic patients with cervical stenosis and spinal cord compression. The presence of a low signal on T1-weighted images, high signal on T2-weighted images, and the presence of cord atrophy on preoperative MR images are indicators of a poor outcome in CSM. There is Class III evidence to show that anterior or posterior surgical approaches that effectively decompress the cervical canal promote short-term improvements in outcome. However, there appears to be a risk of late kyphosis in patients who undergo laminectomy or anterior cervical discectomy alone compared with patients in whom decompression is combined with fusion. The use of BMP-2 is discouraged for anterior cervical spine surgery based on evidence suggesting that the risks outweigh any potential benefits. Finally, in patients with symptomatic cervical radiculopathy, arthroplasty achieves outcomes that are equivalent to anterior cervical decompression and fusion, although evidence for superiority is lacking. Further prospective longitudinal data are required to better define the role and timing of surgical intervention in CSM and to determine the appropriate use of cervical arthroplasty in the management of symptomatic cervical degenerative disc disease.

Entities:  

Mesh:

Year:  2009        PMID: 19769487     DOI: 10.3171/2009.5.SPINE09210

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  27 in total

1.  Predictors of morbidity and mortality among patients with cervical spondylotic myelopathy treated surgically.

Authors:  I David Kaye; Bryan J Marascalchi; Angel E Macagno; Virginie A Lafage; John A Bendo; Peter G Passias
Journal:  Eur Spine J       Date:  2015-05-23       Impact factor: 3.134

Review 2.  Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review.

Authors:  Lindsay A Tetreault; Alina Karpova; Michael G Fehlings
Journal:  Eur Spine J       Date:  2013-02-06       Impact factor: 3.134

3.  Evaluation of the rate of decompression in anterior cervical corpectomy using an intra-operative computerized tomography scan (O-Arm system).

Authors:  Francesco Costa; Massimo Tomei; Marco Sassi; Andrea Cardia; Alessandro Ortolina; Domenico Servello; Maurizio Fornari
Journal:  Eur Spine J       Date:  2011-09-24       Impact factor: 3.134

4.  Introduction, rationale, and methodology.

Authors:  Jeffrey J Olson; Timothy Charles Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2014-04-09       Impact factor: 4.130

5.  Retrospective evaluation of efficiency and safety of an anterior percutaneous approach for cervical discectomy.

Authors:  Michael Schubert; Susanne Merk
Journal:  Asian Spine J       Date:  2014-08-19

Review 6.  A summary of assessment tools for patients suffering from cervical spondylotic myelopathy: a systematic review on validity, reliability and responsiveness.

Authors:  Anoushka Singh; Lindsay Tetreault; Adrian Casey; Rodney Laing; Patrick Statham; Michael G Fehlings
Journal:  Eur Spine J       Date:  2013-09-05       Impact factor: 3.134

7.  Perioperative Risks Associated with Cervical Spondylotic Myelopathy Based on Surgical Treatment Strategies.

Authors:  Angel Macagno; Shian Liu; Bryan J Marascalchi; Sun Yang; Anthony J Boniello; John A Bendo; Virginie C Lafage; Peter G Passias
Journal:  Int J Spine Surg       Date:  2015-06-19

8.  Magnetic Resonance Imaging Biomarker of Axon Loss Reflects Cervical Spondylotic Myelopathy Severity.

Authors:  Rory K J Murphy; Peng Sun; Junqian Xu; Yong Wang; Samir Sullivan; Paul Gamble; Joanne Wagner; Neill N Wright; Ian G Dorward; Daniel Riew; Paul Santiago; Michael P Kelly; Kathryn Trinkaus; Wilson Z Ray; Sheng-Kwei Song
Journal:  Spine (Phila Pa 1976)       Date:  2016-05       Impact factor: 3.468

9.  Cervical disc herniation and cervical spondylosis surgically treated by Cloward procedure: a 10-year-minimum follow-up study.

Authors:  Cesare Faldini; Danilo Leonetti; Matteo Nanni; Alberto Di Martino; Luca Denaro; Vincenzo Denaro; Sandro Giannini
Journal:  J Orthop Traumatol       Date:  2010-06-09

10.  Assessment of the minimum clinically important difference in neurological function and quality of life after surgery in cervical spondylotic myelopathy patients: a prospective cohort study.

Authors:  Feifei Zhou; Yilong Zhang; Yu Sun; Fengshan Zhang; Shengfa Pan; Zhongjun Liu
Journal:  Eur Spine J       Date:  2015-09-01       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.